Search Results - Tim Card
- Showing 1 - 5 results of 5
-
1
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qua... by Amy Fuller, Jennie Hancox, Kavita Vedhara, Tim Card, Christian Mallen, Jonathan S. Nguyen Van-Tam, Abhishek Abhishek
Published in PLoS ONE (2022-01-01)Get full text
Article -
2
Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study by Abhishek Abhishek, Christian D Mallen, Georgina Nakafero, Matthew J Grainge, Tim Card, Jonathan S Nguyen Van-Tam
Published in BMJ Open Gastroenterology (2024-05-01)Get full text
Article -
3
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic... by Abhishek Abhishek, Danielle van der Windt, Christopher Carroll, Matthew J Grainge, Richard Riley, Joanna Leaviss, Munira Essat, Tim Card
Published in RMD Open (2024-02-01)Get full text
Article -
4
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation by Abhishek Abhishek, Christian D Mallen, Guruprasad P Aithal, Christopher P Fox, Georgina Nakafero, Richard Riley, Matthew Grainge, Hywel C Williams, Maarten W Taal, Tim Card, Matthew D Stevenson
Published in RMD Open (2024-02-01)Get full text
Article -
5
Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluationResearch in co... by Georgina Nakafero, Tim Card, Matthew J. Grainge, Hywel C. Williams, Maarten W. Taal, Guruprasad P. Aithal, Christopher P. Fox, Christian D. Mallen, Danielle A. van der Windt, Matthew D. Stevenson, Richard D. Riley, Abhishek Abhishek
Published in EClinicalMedicine (2023-10-01)Get full text
Article